TransMedics Stock Has a Post-Holiday Test — The Next Catalyst Is Already on the Calendar
TransMedics Group shares edged up before the regular Nasdaq open on Tuesday, quoted at $68.94, about 0.2% above the previous close, as investors returned to a stock still trading on the fallout from its May earnings report. At that level, the organ-transplant technology company had a market value of about $2.5 billion. The timing matters. Nasdaq was shut on Monday, May 25, for Memorial Day, and its posted core session runs from 9:30 a.m. to 4 p.m. Eastern time; Tuesday’s early move came in premarket trading, the lighter session before the official open.